文献速递儿童呼吸

随机临床试验比较呼吸增强型与常规雾化器治疗儿童急性哮喘

Randomized Clinical Trial Comparing Breath-Enhanced to Conventional Nebulizers in the Treatment of Children with Acute Asthma.
PubMed 文献 · J Pediatr · 2018-11-02

该随机临床试验纳入6至18岁急诊中重度急性哮喘且初始FEV1低于预计值70%的患儿,比较呼吸增强型与常规喷射雾化器递送5mg沙丁胺醇的疗效。

要点

  • 临床哮喘评分、急诊停留时间、处置及副作用两组无显著差异。
  • 常规喷射雾化器可能更有效递送沙丁胺醇给急性哮喘儿童。

核心结论

  • 常规喷射雾化器递送沙丁胺醇在改善FEV1方面显著优于呼吸增强型雾化器,临床指标无显著差异。

研究设计与样本

  • 随机临床试验纳入6至18岁急诊急性哮喘且初始FEV1低于预计值70%的患儿,随机接受呼吸增强型或常规喷射雾化器递送5mg沙丁胺醇。
  • 497例患者评估资格,118例入组,107例可用于主要结局分析。

主要发现

  • 临床哮喘评分、急诊停留时间、处置及副作用两组无显著差异。

关键数值与推荐

  • 主要结局为FEV1变化,次要结局包括临床哮喘评分变化、急诊停留时间、处置及副作用。

临床怎么用

  • 对于6至18岁中重度急性哮喘患儿,常规喷射雾化器可能比呼吸增强型雾化器更有效改善FEV1。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the efficacy of a breath-enhanced and a conventional jet nebulizer in the treatment of children with moderate to severe acute asthma. STUDY DESIGN: We enrolled subjects between 6 and 18 years of age presenting to the emergency department (ED) with acute asthma and an initial forced expiratory volume in 1 second (FEV1) <70% of predicted. We excluded patients with chronic disease, who required immediate resuscitation, or failed spirometry. Subjects were randomized to breath-enhanced or conventional jet delivery of a 5-mg albuterol treatment. Our primary outcome was change in FEV1, and secondary outcomes included change in clinical asthma scores, ED length of stay, disposition, and side effects. Student t test and multivariable linear regression were used to evaluate the primary outcome. RESULTS: In total, 497 patients were assessed for eligibility with 118 enrolled and 107 subjects available for analysis of the primary outcome. Improvement in FEV1 was significantly greater with conventional jet nebulizer (mean ΔFEV1 +13.8% vs +9.1%, P = .04). This difference remained significant after adjustment for baseline differences. Subgroup analysis of 57 subjects with spirometry meeting American Thoracic Society/European Respiratory Society guidelines yielded similar results (mean ΔFEV1 +14.5% vs +8.5%, P=.03). There were no significant differences in clinical asthma scores, ED length of stay, disposition, or side effects. CONCLUSIONS: Albuterol delivered via conventional jet nebulizer resulted in significantly greater improvement in FEV1 than albuterol delivered by breath-enhanced nebulizer, without significant differences in clinical measures. Conventional jet nebulizers may deliver albuterol to children with acute asthma more effectively than breath-enhanced nebulizers. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02566902.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Gardiner MA, Wilkinson MH. Randomized Clinical Trial Comparing Breath-Enhanced to Conventional Nebulizers in the Treatment of Children with Acute Asthma. J Pediatr. 2018. PMID: 30392872. doi:10.1016/j.jpeds.2018.08.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。